Journey Medical Corp (DERM) bonds
DERMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3033% below fair value
$3.90+0.20 (+5.41%)
Close on Nov 17, 2026Market cap $110.08MP/E –Yield –
Debt
Borrowings on the balance sheet, Jun 30, 2026
Total debt
$25.47M
$5.00M due within a year
Net debt
-$171.00K
After $25.64M of cash
Implied interest rate
14.75%
FY2025 interest ÷ average debt
Interest coverage
-2.2×
FY2025 operating income ÷ interest
Total debt by fiscal year
Long-term plus current debt, USD
Notes and loans outstanding
As tagged in Journey Medical's 10-Q for the period ended Jun 30, 2026
Journey Medical's filings do not break debt down by note
The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.
Credit facilities
Revolving credit lines and other committed borrowing capacity
| Facility | Size |
|---|---|
| Term loan | $25.00M |
See a number that looks wrong?